Early detection of
Peripheral Arterial Disease

Next generation non-invasive patient diagnostics within minutes.

Request Information

Ankle-Brachial Index (ABI)


The ABI is an indicator of Peripheral Arterial Disease (PAD), a cardiovascular disease with a high mortality rate.

Unfortunately, the ABI is not measured routinely because its traditional measuring with Doppler ultrasound is long and complex.

Peripheral Artery Disease (PAD) is highly underdiagnosed.
2 out of 3 patients with PAD do not show signs or symptoms.
The cost to treat individuals with progressive PAD is astronomical.

VitalScan ABI solutions enable fast and effective measurement of the Ankle-Brachial Index.

Automated Ankle-Brachial Index system with its 4 cuff technology allows simultaneous segmental measurement of the brachial and ankle pressures.

Early PAD detection is vital for these reasons:

70%

of patients with PAD do not have typical symptoms and are not diagnosed

1/3

of asymptomatic patients have masked PAD

29%

of highest risk patients have PAD

13%

adult people affected globally

230 million

adult people affected globally

20 million

Americans have PAD

Why Arterial Vascular Assessment Matters


Peripheral Artery Disease (PAD) is a dominant concern for physicians and is intrinsically linked to arterial health. PAD is the occlusion of arteries due to the buildup of fatty cholesterol deposits called plaque lining the interior of arteries. As plaque formation accumulates, the arteries narrow, stiffen, and decline functionality. Plaque reduces blood flow, usually to the legs, and, if left to worsen, can lead to tissue death or even amputation. Research estimates that eight to 20 million people are affected by PAD in both the U.S. and Europe. Like many other cardiovascular diseases, over three-quarters of the population that develops Peripheral Artery Disease (PAD) do not show symptoms. As a result, patients with PAD have an increased risk of stroke, heart attack, and ischemic attack. PAD patients are six times more likely to die from cardiovascular disease than healthy adults within ten years of being diagnosed.

VitalScan ABI+ enables specialists to isolate issues, track problems and manage patient health using noninvasive oscillometer readings performed automatically and efficiently.


Request Information

VitalScan ABI+


The VitalScan ABI+ is an innovative system combining cuff-based technology and pulse wave velocity for performing the ankle-brachial index (ABI) and TBI exam. The assessment assists in the diagnosis of peripheral arterial disease (PAD).

The VitalScan ABI+ provides new technologies better to serve the needs of health care providers and patients.

This new technology significantly improves ankle and pressure determination and PAD assessment over traditional forms of oscillometer ankle pressure estimation.

The VitalScan ABI+ has 4 blood pressure cuffs with options up to 8 cuffs with pulse volume recording (PVR) technology.

The system also includes one PPG Sp02 finger and two toe pressure sensors for an accurate TBI assessment.
The VitalScan ABI+ system is a Class II medical device that is US FDA 510(K) cleared.

VitalScan ABI+ testing procedure is covered by the most major insurance providers, under CPT code 93922 and 93923.

Designed for Clinicians, by Clinicians

Request Information